Independence Blue Cross began limiting coverage of GLP-1 drugs on Jan. 1 to some medical conditions, but not obesity or weight loss.

Drugmakers have poured small fortunes into the development of weight loss medicines in the past few years in attempts to lead ...

Some users experience side-effects such as nausea, diarrhoea and fatigue. Other clinical studies have found that some ...

The popular weight-loss drugs known as GLP-1 receptor agonists, which were originally meant to treat diabetes, surged in ...

While popular drugs like Ozempic and Wegovy are only available as injections, drugmaker Novo Nordisk is working on a more ...

If you’re in a calorie deficit – either from dieting or while taking a weight loss drug – these exercises help direct your ...

Women are increasingly turning to weight loss drugs like Wegovy and Mounjaro due to unrealistic beauty standards. Many use ...

Dr. Sue Mitchell is an experienced gastroenterologist with a background in functional medicine, internal medicine and ...